Jean Paul Gagnon, Ph'D'

1
(No Transcript)
2

• Jean Paul Gagnon, Ph.D.

3
Figure 1 - Financial Results FY9004 FY00-04 vs.
FY9599 vs. FY9094 Actuals
4
Figure 2 - Reference Standards, USP-NF, USP-PF
Revenue FY00-04 vs. FY9599 Actuals
5
Figure 3 - Revenue by Public Health
ProgramFY0004 Actuals
6
Figure 4 USP Headcount FY00-04
7
Figure 5 - Investments (at Market Value) FY00-04
vs. FY9599 vs. FY9094 Actuals
8
Figure 6 - Weighted Return on Investment
PortfolioFY0004 Actuals
9
Figure 7 Other Significant Achievements

• Financing the lab and office expansion
• Bonds issued at 3.728 interest rate
• Received Moodys A2 investment grade rating
• Excellent external financial audits
• Recognized by auditors for strong financial
  controls and management
• Implemented appropriate best practices from
  Sarbanes Oxley Act. Auditors use USP as an
  example of effective SOX implementation for a not
  for profit.
• Financial systems improvements
• Annual edition of USP-NF levels operating and
  cash cycles
• Excellent credit management